Bleakley Financial Group LLC Has $1.22 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Bleakley Financial Group LLC lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 58.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,265 shares of the company’s stock after selling 23,224 shares during the quarter. Bleakley Financial Group LLC’s holdings in GE HealthCare Technologies were worth $1,221,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Allianz SE increased its holdings in shares of GE HealthCare Technologies by 165.2% during the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. increased its holdings in shares of GE HealthCare Technologies by 130.7% in the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the last quarter. Godsey & Gibb Inc. acquired a new position in GE HealthCare Technologies in the 3rd quarter valued at about $26,000. Oakworth Capital Inc. grew its position in shares of GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after purchasing an additional 394 shares during the last quarter. Finally, Piscataqua Savings Bank increased its position in GE HealthCare Technologies by 173.4% during the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after buying an additional 300 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

GEHC has been the topic of several recent research reports. BTIG Research raised their target price on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Stifel Nicolaus boosted their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research note on Wednesday, February 4th. Bank of America raised their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Wells Fargo & Company raised their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Finally, Evercore boosted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Price Performance

GEHC opened at $84.05 on Wednesday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The firm has a market cap of $38.31 billion, a P/E ratio of 18.43, a PEG ratio of 1.85 and a beta of 1.08. The firm has a 50-day moving average of $82.29 and a 200 day moving average of $78.25. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $92.20.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the prior year, the business earned $1.45 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.